High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?-Reference-Cited by-同舟云学术

High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?

Published:2023-07 Issue: Volume:376 Page:53-62
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Simonen Piia,Öörni Katariina,Sinisalo Juha,Strandberg Timo E.,Wester Ingmar,Gylling Helena^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference76 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017

2. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel;Borén;Eur. Heart J.,2020

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins;Lancet,2005

4. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials;Lancet,2010

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Cell Analysis Reveals Critical Role of Macrophage Epsin in Regulating Origin of Foam Cell in Atherosclerosis;2024-09-01

2. Opportunistic Detection of Phytosterolemia During Genetic Testing for FH: Case Series and Contextual Review;The Journal of Clinical Endocrinology & Metabolism;2024-06-25

3. New Insights Into the Importance of Dietary Cholesterol in Preventing Cardiovascular Disease;Endocrine Practice;2024-06

4. Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy;Pharmaceuticals;2024-03-01

5. The profile of cholesterol metabolism does not interfere with the cholesterol-lowering efficacy of phytostanol esters;Clinical Nutrition;2024-03